Immunovant, Inc.
IMVT· Nasdaq
Immunovant, Inc.
- Last sale
- Oct 1, 2026 · -0.21%
- Market cap
- $6.95B
- 206.55M shares
- Filings
- 642
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Net Interest Income
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2024 | 2024-03-31 | $24,948,000 | reported | |
| FY 2023 | 2023-03-31 | $7,578,000 | reported | |
| FY 2022 | 2022-03-31 | $0 | reported |
Immunovant, Inc. · CIK 1764013 · Engraved from SEC EDGAR
